tirzepatide and contrave Weight Loss Drug Helped This Nurse Practitioner Lose 100 lbs Contrave vs Mounjaro: Weight Loss

Most recently in 2021, Wegovy was approved by the FDA for weight loss management

Frosting or crystallization on the vial walls, a yellowish tint, or visible particles indicate temperature exposure or chemical breakdown that compromises the medication's therapeutic potency

When compared with placebo or other therapies, GLP-1 agonists were associated with an increased risk of biliary disease [23]: Overall biliary disease: RR 1.37(95% CI 1.231.52) Cholelithiasis: RR 1.27 (95% CI 1.101.47) Cholecystitis: RR 1.36 (95% CI 1.141.62) Mechanisms: Reduced gallbladder motility Rapid weight loss increased cholesterol saturation and gallstone formation

Umpierrez G, Tof Povedano S, Prez Manghi F, Shurzinske L, Pechtner V